Members Capital Advisors Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,005
Closed -$97.1K 25
2025
Q2
$97.1K Hold
4,005
0.11% 30
2025
Q1
$101K Hold
4,005
0.12% 29
2024
Q4
$106K Hold
4,005
0.1% 29
2024
Q3
$116K Hold
4,005
0.13% 29
2024
Q2
$112K Hold
4,005
0.13% 29
2024
Q1
$111K Hold
4,005
0.31% 27
2023
Q4
$115K Sell
4,005
-24,450
-86% -$739K 0.33% 27
2023
Q3
$944K Hold
28,455
1.17% 34
2023
Q2
$1.04M Sell
28,455
-10,651
-27% -$415K 1.07% 38
2023
Q1
$1.6M Hold
39,106
1.15% 39
2022
Q4
$2M Sell
39,106
-16,684
-30% -$800K 1.44% 26
2022
Q3
$2.44M Hold
55,790
1.92% 10
2022
Q2
$2.92M Hold
55,790
2.12% 5
2022
Q1
$2.89M Buy
55,790
+5,585
+11% +$290K 1.85% 10
2021
Q4
$2.96M Hold
50,205
1.52% 13
2021
Q3
$2.16M Hold
50,205
1.17% 18
2021
Q2
$1.97M Hold
50,205
1.22% 19
2021
Q1
$1.82M Hold
50,205
1.39% 21
2020
Q4
$1.85M Sell
50,205
-11,491
-19% -$421K 1.57% 21
2020
Q3
$2.15M Buy
+61,696
New +$2.16M 2.02% 9
2020
Q1
Sell
-44,832
Closed -$1.67M 32
2019
Q4
$1.67M Buy
+44,832
New +$1.6M 1.27% 18

Other funds holding PFE

Members Capital Advisors Inc's PFE Position: Q3 2025 in Review

Members Capital Advisors Inc sold out of Pfizer (PFE) in Q3 2025, closing a stake of 4,005 shares — an estimated $97.1K sold.

Members Capital Advisors Inc first reported a position in PFE in Q4 2019 and held it in 21 quarters. The position peaked at $2.96M in Q4 2021. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Members Capital Advisors Inc reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Members Capital Advisors Inc sold 4,005 Pfizer shares in Q3 2025, an estimated $97.1K.
  • Members Capital Advisors Inc first reported a position in Pfizer in Q4 2019 and held it in 21 quarters.
  • Members Capital Advisors Inc's Pfizer position peaked at $2.96M in Q4 2021.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Members Capital Advisors Inc's 13F filing for Q3 2025, filed 24 Oct 2025.